Human papillomavirus gene expression is controlled by host cell splicing factors

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 773-777

  Klymenko, Tetyana ^a   Graham, Sheila V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Alternative splicing; Gene expression; Human papillomavirus (HPV); RNA processing; Serine arginine rich splicing factor (SRSF); Virus life cycle

Indexed keywords

CAPSID PROTEIN L1; CCAAT ENHANCER BINDING PROTEIN BETA; MESSENGER RNA; PROTEIN C MYB; SERINE ARGININE RICH PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR YY1; VIRUS RNA;

ALTERNATIVE RNA SPLICING; CONFERENCE PAPER; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS GENOME; VIRUS REPLICATION; WART VIRUS;

ALTERNATIVE SPLICING; CARRIER PROTEINS; HUMANS; PAPILLOMAVIRIDAE; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84864384254     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120079     Document Type: Conference Paper

References (42)

1. de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U. and zur Hausen, H. (2004) Classification of papillomaviruses. Virology 324, 17-27 (Pubitemid 38737395)
2. zur Hausen, H. (2009) Papillomaviruses in the causation of human cancers: a brief historical account. Virology 384, 260-265
3. Syrjänen, S. (2010) The role of human papillomavirus infection in head and neck cancers. Ann. Oncol. 21 (Suppl. 7), vii243-vii245
4. Longworth, M.S. and Laimins, L.A. (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68, 362-372 (Pubitemid 38756870)
5. Middleton, K., Peh, W., Southern, S., Griffin, H., Sotlar, K., Nakahara, T., El-Sherif, A., Morris, L., Seth, R., Hibma, M. et al. (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 77, 10186-10201 (Pubitemid 37129663)
6. Stanley, M.A. (2006) Human papillomavirus vaccines. Rev. Med. Virol. 16, 139-149
7. Graham, S.V. (2008) Papillomavirus 3′ UTR regulatory elements. Front. Biosci. 13, 5646-5663
8. Graham, S.V. (2010) Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol. 5, 1493-1506
9. Doorbar, J., Parton, A., Hartley, K., Banks, L., Crook, T., Stanley, M. and Crawford, L. (1990) Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178, 254-262 (Pubitemid 20276690)
10. Ozbun, M.A. and Meyers, C. (1997) Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71, 5161-5172 (Pubitemid 27258188)
11. Glahder, J.A., Hansen, C.N., Vinther, J., Madsen, B.S. and Norrild, B. (2003) A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA. J. Gen. Virol. 84, 3429-3441 (Pubitemid 37540771)
12. Milligan, S.G., Veerapraditsin, T., Ahamat, B., Mole, S. and Graham, S.V. (2007) Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360, 172-181 (Pubitemid 46335715)
13. Hansen, C.N., Nielsen, L. and Norrild, B. (2010) Activities of E7 promoters in the human papillomavirus type 16 genome during cell differentiation. Virus Res. 150, 34-42
14. Frattini, M.G., Lim, H.B., Doorbar, J. and Laimins, L.A. (1997) Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71, 7068-7072 (Pubitemid 27358066)
15. Grassmann, K., Rapp, B., Maschek, H., Petry, K.U. and Iftner, T. (1996) Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70, 2339-2349
16. Hebner, C.M. and Laimins, L.A. (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16, 83-97
17. Favre, M., Breitburd, F., Croissant, O. and Orth, G. (1977) Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses. J. Virol. 21, 1205-1209 (Pubitemid 8163126)
18. Stunkel, W. and Bernard, H.U. (1999) The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J. Virol. 73, 1918-1930 (Pubitemid 29098093)
19. del Mar Pena, L.M. and Laimins, L.A. (2001) Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J. Virol. 75, 10005-10013
20. Carson, A. and Khan, S.A. (2006) Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation. J. Virol. 80, 4356-4362
21. Wooldridge, T.R. and Laimins, L.A. (2008) Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology 374, 371-380
22. Stoler, M.H. and Broker, T.R. (1986) In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum. Pathol. 17, 1250-1258 (Pubitemid 17023680)
23. Stoler, M.H., Wolinsky, S.M., Whitbeck, A., Broker, T.R. and Chow, L.T. (1989) Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172, 331-340 (Pubitemid 19221458)
24. Koffa, M.D., Graham, S.V., Takagaki, Y., Manley, J.L. and Clements, J.B. (2000) The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc. Natl. Acad. Sci. U.S.A. 97, 4677-4682 (Pubitemid 30238617)
25. McPhillips, M.G., Veerapraditsin, T., Cumming, S.A., Karali, D., Milligan, S.G., Boner, W., Morgan, I.M. and Graham, S.V. (2004) SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J. Virol. 78, 10598-10605 (Pubitemid 39258386)
26. Mole, S., Veerapraditsin, T., McPhillips, M.G. and Graham, S.V. (2006) Regulation of splicing-associated SR proteins by HPV-16. Biochem. Soc. Trans. 34, 1145-1147 (Pubitemid 46769007)
27. Mole, S., Milligan, S.G. and Graham, S.V. (2009) Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J. Virol. 83, 357-367
28. Mole, S., McFarlane, M., Chuen-Im, T., Milligan, S.G., Millan, D. and Graham, S.V. (2009) RNA splicing factors regulated by HPV16 during cervical tumour progression. J. Pathol. 219, 383-391
29. Graham, S.V. and Gaston, K. (2012) The regulation of human papillomavirus gene expression by the E2 protein: keeping a finger in every pie. In Small DNA Tumour Viruses (Gaston, K. ed.), pp. 37-53, Horizon Press, Norwich
30. Long, J.C. and Caceres, J.F. (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem. J. 417, 15-27
31. Jia, R., Liu, X., Tao, M., Kruhlak, M., Guo, M., Meyers, C., Baker, C.C. and Zheng, Z.M. (2009) Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J. Virol. 83, 167-180
32. Somberg, M. and Schwartz, S. (2010) Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3′-splice site on the HPV-16 genome. J. Virol. 84, 8219-8230
33. Cumming, S.A., McPhillips, M.G., Veerapraditsin, T., Milligan, S.G. and Graham, S.V. (2003) Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5′ splice sites that bind a U1 snRNP-like complex. J. Virol. 77, 5167-5177 (Pubitemid 36460931)
34. Stanley, M.A., Browne, H.M., Appleby, M. and Minson, A.C. (1989) Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43, 672-676 (Pubitemid 19110104)
35. Isaacson, E., Wang, Q., Roberts, I., Pagliarulo, E., Jackson, D., Untersperger, C., Coleman, N., Griffin, H. and Doorbar, J. (2012) Reconstruction of human papillomavirus-16-mediated early-stage neoplasia implicates E6/E7 deregulation and the loss of contact inhibition in neoplastic progression. J. Virol. 86, 6358-6364
36. Zhao, K.N. and Chen, J. (2011) Codon usage roles in human papillomavirus. Rev. Med. Virol. 21, 397-411
37. Mossadegh, N., Gissmann, L., Muller, M., Zentgraf, H., Alonso, A. and Tomakidi, P. (2004) Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 326, 57-66 (Pubitemid 38943006)
38. Stacey, S.N., Jordan, D., Williamson, A.J., Brown, M., Coote, J.H. and Arrand, J.R. (2000) Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J. Virol. 74, 7284-7297 (Pubitemid 30614251)
39. Tang, S., Tao, M., McCoy, Jr, J.P. and Zheng, Z.M. (2006) The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J. Virol. 80, 4249-4263
40. Schmitt, M., Dalstein, V., Waterboer, T., Clavel, C., Gissmann, L. and Pawlita, M. (2010) Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res. 70, 249-256
41. Concha, M., Wang, X., Cao, S., Baddoo, M., Fewell, C., Lin, Z., Hulme, W., Hedges, D., McBride, J. and Flemington, E.K. (2012) Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. J. Virol. 86, 1458-1467
42. Gatherer, D., Seirafian, S., Cunningham, C., Holton, M., Dargan, D.J., Baluchova, K., Hector, R.D., Galbraith, J., Herzyk, P., Wilkinson, G.W. and Davison, A.J. (2011) High-resolution human cytomegalovirus transcriptome. Proc. Natl. Acad. Sci. U.S.A. 108, 19755-19760